K86.0 K86.1 K86.8
Conditions
Interventions
Group 1: SF-36 questionaire, lab work (Haemoglobin, Ferritin, HbA1c), weight/hight/BMI, Stool samples, supplementation of the study Probiotics (Verum) for 12 weeks.
Verum (OMNi BiOTiC® HETOX) contain
Sponsors
Johannes Wesling Klinikum Minden
Eligibility
Sex/Gender
All
Age
18 Years to 81 Years
Inclusion criteria
Inclusion criteria: Patient has to be able to understand and accept the participation, has to have a chronic pancratitis
Exclusion criteria
Exclusion criteria: Patient doesn't want to participate, age is outside the requested range, antibiotics have been taken in the previous four weeks, other probiotics are taken on a regular basis, alcohol abuse of more than 80 g ethanol/day, patient is pregnant or currently breast feeding, maligne comorbidity, colitis ulcerosa/crohn's disease, IBS, infectious gastroenteritis within the previous 4 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary Outcome is reached if the single domain Score of the SF-36 questionaire at T#2 is = 10 point above T#1 | — |
Secondary
| Measure | Time frame |
|---|---|
| • bowel movement frequency and consitency • intensity and frequency of pain • weight/BMI • lab works (Ferritin, HbA1c, Haemoglobin) • alterations in intestinal microbiotia | — |
Countries
Germany
Outcome results
None listed